Browse diseases

…althy donors (mean age 2.7) from PMID: 32415257. Most B-ALL and AML samples (107/114) were obtained at diagnosis. All samples were …

…ort. 30 CAYA were treated at the RP2D; 28 with B-ALL and 2 with Burkitt lymphoma. Across patients with B-ALL, 20 (71.4%) patients developed cyto…

…rative potential for chimeric antigen receptor (CAR) T-cells in B-cell acute lymphoblastic leukemia (B-ALL), efficacy can be limited by life-threatening adverse events suc…

…cacy of CAR-NK cells for treating pediatric relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) are lacking.We report a challenging case of a boy w…

…he GD2 ganglioside, in pediatric sarcomas by targeting Her2, in Hodgkin’s disease by targeting CD30, in T cell lymphoblastic leukemia by targetin…

…B cell acute lymphoblastic leukaemia (B-ALL) infrequently presents with undetectable or very low per…

…avily pretreated pediatric patients with relapsed or refractory B-ALL. Treatment indications were CD19-negative blast population (n=5…

…lson AL, Huang W, et al. Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety. Cancer Disc…